ExpertiseUpdated on 25 February 2026
Oxeltis _ Bridge the gap between biology and chemical matter...
About
We address this by:
Seamless integration of in silico design (CADD, SBDD, LBDD, AI/ML) in partnership with Molecular Forecaster (Montreal) and Assay development/in vitro biological screening in partnership with Partex.AI Labs
Rapid hit-to-lead and lead optimization, with a track record of delivering high-quality compounds efficiently and a highly skill team of chemists (50% Ph.D., 50% M.Sc.)
Expertise in complex and enabling chemistries, supported by our hybrid SFC platform for rapid purification and scale-up (up to 25g/day) of chiral/achiral mixtures.
Oxeltis, France-based CRO specialized in medicinal and fine organic chemistry can support early small molecule drug disocvery programs to mature at Hit to Lead and Lead optimization stage.
Field
- Biotech, Pharma and Cosmetics
Organisation
Similar opportunities
Expertise
- Biotech, Pharma and Cosmetics
Elmeri Jokinen
CEO at Aurlide Oy
Turku, Finland
Partnership
Sandra von Meier
Head of Business Development Life Science at Terra Quantum AG
Munich, Germany
Expertise
Integrated Synthetic medicinal Chemistry & Process Development Expertise
- Healthcare
- Biotech, Pharma and Cosmetics
Jay Raval
BD Manager at Zasya Life Sciences
Ahmedabad, India